M2 Pharma - Generics

Italy's regulatory body clears trial of osteoporosis drug to treat COVID-19

27 October 2020 - The main medical regulator in Italy gave the go-ahead on 27 October 2020 for human clinical trials on raloxifene, a generic osteoporosis drug that researchers hope may also help redu...

Dr. Reddy's re-distributes OTC Famotidine Tablets USP in 10 mg and 20 mg in the US antacid market

20 October 2020 - Pharmaceutical company Dr. Reddy's Laboratories Ltd (BSE:500124) (NYSE:RDY) on Tuesday reported the re-launch of its US Food and Drug Administration (USFDA) approved over-the-co...

Lipella Pharmaceuticals Initiates Its Phase-2a Clinical Trial of LP-10 for Hemorrhagic Cystitis

16 October 2020 - - US-based clinical-stage pharmaceutical company Lipella Pharmaceuticals Inc has begun recruiting patients in the company's phase 2a clinical trial to study the dose-dependent, ...

PhaseBio Doses First Patients in Canada as Part of the REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of the Antiplatelet Effects of Ticagrelor

6 October 2020 - - US-based biopharmaceutical company PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) has expanded its pivotal Phase 3 REVERSE-IT trial for its lead product candidate bentracimab (f...

Antiviral drug remdesivir rationed in Britain as COVID-19 hospitalisations increase

6 October 2020 - Britain's health ministry said on 6 October 2020, that Britain has rationed its supplies of the antiviral drug remdesivir and is prioritising COVID-19 patients who need it most i...

Dr. Reddy's Laboratories Launches Generic Version of Sapropterin Dihydrochloride Tablets for Oral Use in the US Market

5 October 2020 - - Indian drugmaker Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use, the...